Galmed Pharmaceuticals

Yahoo Finance • 6 months ago

Key Catalysts Emerge in Oncology, Synthetic Biology, and M&A Activity as Markets Open

DENVER, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Markets open this morning with a distinctly biotech-heavy narrative delivering milestone developments. Zymeworks and Jazz Drop Landmark Phase 3 Data: Ziihera Positioned as New HER2 Standard in F... Full story

Yahoo Finance • 8 months ago

Galmed files to sell 7.5M shares of common stock for holders

* Galmed Pharmaceuticals (NASDAQ:GLMD [https://seekingalpha.com/symbol/GLMD]) filed to sell 7.5M shares of common stock for holders. * This preliminary prospectus is not an offer to sell. * Filing [https://seekingalpha.com/filing/103... Full story